Literature DB >> 10329044

Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.

H J Garbán1, B Bonavida.   

Abstract

Fas-mediated apoptosis represents one major mechanism by which tumor cells can be eliminated by activated cytotoxic immune lymphocytes. Previously, we have reported that interferon-gamma (IFN-gamma) sensitizes human ovarian carcinoma cell lines to Fas-mediated apoptosis. Furthermore, IFN-gamma, together with many other proinflammatory cytokines (TNF-alpha, IL-1beta, LPS, etc.), can stimulate the induction of inducible nitric oxide synthase (iNOS) and the generation of nitric oxide (NO). In this study, we examined whether nitric oxide is a mediator of IFN-gamma-induced sensitization of human ovarian carcinoma cell lines (A2780 and AD10) to Fas-mediated apoptosis and whether NO regulates the expression of the Fas receptor. Treatment of quiescent A2780 and AD10 ovarian carcinoma cells with IFN-gamma alone induced the expression of iNOS mRNA as examined by RT-PCR. There was accumulation of nitrite in the culture medium of IFN-gamma-treated cells, suggesting the generation of NOx. Like IFN-gamma, the use of exogenous sources of NO (S-nitroso-N-acetylpenicillamine (SNAP)) mimicked the sensitization of both cell lines to anti-Fas cytotoxic antibody (CH11) by IFN-gamma. Endogenously produced NO, by IFN-gamma pretreatment or exogenous nitrodonors, resulted in the upregulation of Fas receptor mRNA and protein expression. Blocking iNOS activity by NG-monomethyl-l-arginine (l-NMA) significantly reduced the sensitization, Fas mRNA, and protein expression observed with IFN-gamma pretreatment of the tumor cells. These findings demonstrate that sensitization of human ovarian carcinoma cell lines to Fas-mediated apoptosis by IFN-gamma can be due, in part, to the induction of iNOS and the subsequent upregulation of Fas gene expression by reactive nitrogen intermediates. Thus, the sensitivity of tumor cells to Fas-L-mediated cytotoxic immune lymphocytes can be regulated by the induction of NO or intermediates. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329044     DOI: 10.1006/gyno.1999.5374

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

Review 1.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

2.  Transcription regulator Yin-yang 1: from silence to cancer.

Authors:  Weidong Zhu; Samuel Y Olson; Hermes Garbán
Journal:  Crit Rev Oncog       Date:  2011

3.  Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.

Authors:  Eleanor I Ager; Sergey V Kozin; Nathaniel D Kirkpatrick; Giorgio Seano; David P Kodack; Vasileios Askoxylakis; Yuhui Huang; Shom Goel; Matija Snuderl; Alona Muzikansky; Dianne M Finkelstein; Daniel T Dransfield; Laetitia Devy; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2015-02-20       Impact factor: 13.506

4.  Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4.

Authors:  Zhuo Tang; Joseph A Bauer; Bei Morrison; Daniel J Lindner
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 5.  Regulation of apoptosis-related genes by nitric oxide in cancer.

Authors:  Samuel Y Olson; Hermes J Garbán
Journal:  Nitric Oxide       Date:  2008-06-02       Impact factor: 4.427

6.  Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to Apoptosis.

Authors:  Benjamin Bonavida; Ali Jazirehi; Mario I Vega; Sara Huerta-Yepez; Stavroula Baritaki
Journal:  For Immunopathol Dis Therap       Date:  2013

7.  Up-regulation of Fas (CD95) expression in tumour cells in vivo.

Authors:  Naama Peshes-Yaloz; Dalia Rosen; Paul M Sondel; Peter H Krammer; Gideon Berke
Journal:  Immunology       Date:  2007-04       Impact factor: 7.397

Review 8.  Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics.

Authors:  Benjamin Bonavida; Hermes Garban
Journal:  Redox Biol       Date:  2015-08-18       Impact factor: 11.799

9.  rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition.

Authors:  Bohuslav Melichar; Wei Hu; Rebecca Patenia; Karolina Melicharová; Stacie T Gallardo; Ralph Freedman
Journal:  J Transl Med       Date:  2003-09-19       Impact factor: 5.531

10.  Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells.

Authors:  S Seah; I C C Low; J L Hirpara; K Sachaphibulkij; G Kroemer; C Brenner; S Pervaiz
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.